(Total Views: 249)
Posted On: 06/08/2017 11:29:57 AM
Post# of 72447
When will Prurisol results be available? We're using a CRO. Extrapolating good results. Hard to get moderate to severe patients enrolled. Very well designed Phase 2B. On track for results 3Q this year
Orally administered drugs have big role. Significant deals have been made after phase 2B trials. If we meet results of Otezla after Phase 2B, would command considerable attention in industry. Discussions under CDA with pharmas confirm, big market.
Will have to wait and see what results actually are. Interim analysis of patients who have completed at least 6 weeks, will give us first look at results. 3Q 2017
Orally administered drugs have big role. Significant deals have been made after phase 2B trials. If we meet results of Otezla after Phase 2B, would command considerable attention in industry. Discussions under CDA with pharmas confirm, big market.
Will have to wait and see what results actually are. Interim analysis of patients who have completed at least 6 weeks, will give us first look at results. 3Q 2017
(2)
(0)
